Pharmaceuticals, Biotechnology and Life Sciences
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…
Industry veteran brings extensive financial and public biotechnology company experience WATERTOWN, Mass.–(BUSINESS WIRE)–Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing…
Enrollment Initiated in Phase 2 Trial Cohort Evaluating SY-1425 and Azacitidine in Genomically Defined Patients with Relapsed or Refractory Acute…
Announced completion of enrollment in Pfizer’s Phase 3 clinical trial evaluating rivipansel, the Company’s lead investigational drug candidate, in sickle…
– Company Continues to Expand its Gene Therapy Portfolio with the Addition of miniUSH2A Program – – Company to Host…
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM BARCELONA, Spain–(BUSINESS WIRE)–Veeva Systems (NYSE:…
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM PLEASANTON, Calif.–(BUSINESS WIRE)–#CRM—Veeva Systems (NYSE:…
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trials Market Analysis by Phase (Phase I/II/III/IV), by Study Design (Interventional, Observational, Expanded Access), by Indication (Autoimmune,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that members…